Evelo Biosciences to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, March 24, 2022
CAMBRIDGE, Mass., March 17, 2022 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage…
News
Aadi Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
-FYARRO™ approved November 22, 2021 and launched February 23, 2022- –FYARRO added to NCCN® Guidelines…
Alladapt Announces Initiation of Encore Open-Label Extension Study for its Harmony Phase 1/2 Study of ADP101 for Treatment of Food Allergy
Harmony remains ongoing, with OLE study intended to gain insights into long-term exposure to ADP101…
Ikena Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Update
Over $140M in capital raised in initial public offering in 2021; Cash runway through first…
Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
FDA review of NDA for FT218 is ongoing; commercial and launch preparations on-track to support potential commercial…
Cabaletta Bio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
– DesCAARTes™ trial progressing in cohort A5 with presentation of DSG3-CAART clinical and translational data…
Cullinan Oncology to Host CLN-081 Regulatory Update Webinar on March 28, 2022
CAMBRIDGE, Mass., March 17, 2022 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”), a…
Clover’s COVID-19 Vaccine Candidate Demonstrates Durable High Protection and Immune Responses Against Omicron as a Booster
–100% efficacy maintained against severe COVID-19 and 95% efficacy against hospitalization at five months after…
Todos Medical to Present at the Proactive One2One Virtual Forum
– Thursday, March 17, 2022 at 2:00 PM – 2:30 PM ET – NEW YORK,…
CENTOGENE Announces Expansion of Data Access and Collaboration Agreement With Pfizer
In November 2019, CENTOGENE first announced the signing of a data access and collaboration agreement…
Athira Pharma to Host Fourth Quarter and Full Year 2021 Financial Results and Business Update Conference Call on March 24, 2022
BOTHELL, Wash., March 17, 2022 (GLOBE NEWSWIRE) — Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage…
X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Top-line data from pivotal 4WHIM Phase 3 clinical trial in WHIM syndrome expected in 4Q22 Clinical…
MediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN-002 for the Treatment of Advanced NASH in Korea
LA JOLLA, Calif., March 17, 2022 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded…
Bybit Levels Up Compliance Standards With Membership in the VerifyVASP Alliance
Singapore, Singapore–(Newsfile Corp. – March 17, 2022) – Bybit, the fastest growing cryptocurrency exchange, is…
Awakn Life Sciences Receives Regulatory Approval for Flagship Clinic in London to Begin Delivering Treatments
London Clinic Will Begin Delivering Ketamine-Assisted Therapy for Addiction & Mental Health Third Location Adds…
Alephium Unveils Video Creation Contest
Community-Generated Content Drive Underscores User-Driven Momentum Lausanne, Switzerland–(Newsfile Corp. – March 17, 2022) – Following…
Plurilock Adds Brandon Swafford to Advisory Board
Vancouver, British Columbia–(Newsfile Corp. – March 17, 2022) – Plurilock Security Inc. (TSXV: PLUR) (OTCQB:…
Reklaim Launches New SaaS-Based Privacy Subscription to Compliment Growing Compensation Mode
New privacy subscription is immediately accretive to the revenue line. New York, New York–(Newsfile Corp….
FansUnite’s American Affiliate Approved for Customer Acquisition Services In Maryland Sports Betting Market
Vancouver, British Columbia–(Newsfile Corp. – March 17, 2022) – FansUnite Entertainment Inc. (CSE: FANS) (OTCQX:…
Snowflake Launches Healthcare & Life Sciences Data Cloud for Better Patient Care and Business Results
New solution to help providers deliver improved patient outcomes, optimize care delivery, enhance clinical and…